Michael D. Rushton

1.3k total citations
14 papers, 391 citations indexed

About

Michael D. Rushton is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Michael D. Rushton has authored 14 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Rheumatology and 4 papers in Cancer Research. Recurrent topics in Michael D. Rushton's work include Osteoarthritis Treatment and Mechanisms (8 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Michael D. Rushton is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Michael D. Rushton collaborates with scholars based in United Kingdom and United States. Michael D. Rushton's co-authors include John Loughlin, Louise N. Reynard, David A. Young, Matt J. Barter, Kenneth S. Rankin, Ramsay Refaie, Laura Maringele, Yuan Xue, Colin Shepherd and Andrew Skelton and has published in prestigious journals such as Nature Communications, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Michael D. Rushton

14 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Rushton United Kingdom	10	238	200	159	63	53	14	391
Kathleen Cheung United Kingdom	11	202 0.8×	184 0.9×	180 1.1×	47 0.7×	36 0.7×	18	390
Kei Imagawa United Kingdom	6	198 0.8×	291 1.5×	176 1.1×	50 0.8×	110 2.1×	7	435
Kendal McCulloch United Kingdom	4	131 0.6×	186 0.9×	82 0.5×	37 0.6×	47 0.9×	8	305
Liqiang Zhi China	12	210 0.9×	74 0.4×	120 0.8×	55 0.9×	23 0.4×	32	344
Mitsuyasu Iwasawa Japan	9	227 1.0×	58 0.3×	66 0.4×	112 1.8×	10 0.2×	15	328
Dianbo Long China	10	261 1.1×	134 0.7×	196 1.2×	17 0.3×	11 0.2×	19	342
Simon Dai United States	7	281 1.2×	34 0.2×	199 1.3×	149 2.4×	21 0.4×	7	369
Antonia M. Fernández‐Peralta Spain	10	91 0.4×	46 0.2×	99 0.6×	136 2.2×	18 0.3×	29	312
Shi Chen United States	9	286 1.2×	19 0.1×	68 0.4×	75 1.2×	20 0.4×	16	361

Countries citing papers authored by Michael D. Rushton

Since Specialization

Citations

This map shows the geographic impact of Michael D. Rushton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Rushton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Rushton more than expected).

Fields of papers citing papers by Michael D. Rushton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Rushton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Rushton. The network helps show where Michael D. Rushton may publish in the future.

Co-authorship network of co-authors of Michael D. Rushton

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Rushton. A scholar is included among the top collaborators of Michael D. Rushton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Rushton. Michael D. Rushton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rushton, Michael D., et al.. (2022). An shRNA kinase screen identifies regulators of UHRF1 stability and activity in mouse embryonic stem cells. Epigenetics. 17(12). 1590–1607. 2 indexed citations

Rushton, Michael D., Jonathan Higham, Saúl Álvarez–Teijeiro, et al.. (2020). Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation. Nature Communications. 11(1). 3671–3671. 13 indexed citations

Peffers, Mandy J., Katarzyna Goljanek‐Whysall, John A. Collins, et al.. (2016). Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq. PLoS ONE. 11(8). e0160517–e0160517. 24 indexed citations

Shepherd, Colin, Andrew Skelton, Michael D. Rushton, Louise N. Reynard, & John Loughlin. (2016). Expression analysis of the osteoarthritis genetic susceptibility locus mapping to an intron of the MCF2L gene and marked by the polymorphism rs11842874. Osteoarthritis and Cartilage. 24. S226–S226. 11 indexed citations

Rushton, Michael D., Louise N. Reynard, Colin Shepherd, et al.. (2015). Methylation of cartilage DNA is a mediator of genetic risk at several OA susceptibility loci. Osteoarthritis and Cartilage. 23. A71–A72. 1 indexed citations

Rushton, Michael D., David A. Young, John Loughlin, & Louise N. Reynard. (2015). Differential DNA methylation and expression of inflammatory and zinc transporter genes defines subgroups of osteoarthritic hip patients. Annals of the Rheumatic Diseases. 74(9). 1778–1782. 24 indexed citations

Rushton, Michael D., Louise N. Reynard, David A. Young, et al.. (2015). Methylation quantitative trait locus analysis of osteoarthritis links epigenetics with genetic risk. Human Molecular Genetics. 24(25). 7432–7444. 46 indexed citations

Shepherd, Colin, Andrew Skelton, Michael D. Rushton, Louise N. Reynard, & John Loughlin. (2015). Expression analysis of the osteoarthritis genetic susceptibility locus mapping to an intron of the MCF2L gene and marked by the polymorphism rs11842874. BMC Medical Genetics. 16(1). 108–108. 22 indexed citations

Rushton, Michael D., et al.. (2015). Correlation of the Osteoarthritis Susceptibility Variants That Map to Chromosome 20q13 With an Expression Quantitative Trait Locus Operating on NCOA3 and With Functional Variation at the Polymorphism rs116855380. Arthritis & Rheumatology. 67(11). 2923–2932. 18 indexed citations

10.

Rushton, Michael D., et al.. (2014). The osteoarthritis association marked by SNP rs6094710 mediates its effect by reducing the expression of NCOA3 in joint tissues. Osteoarthritis and Cartilage. 22. S237–S237. 1 indexed citations

11.

Rushton, Michael D., Louise N. Reynard, Matt J. Barter, et al.. (2014). Characterisation of the cartilage DNA methylome in knee and hip osteoarthritis using high-density genome-wide analysis. Osteoarthritis and Cartilage. 22. S233–S233. 2 indexed citations

12.

Rushton, Michael D., Louise N. Reynard, Matt J. Barter, et al.. (2014). Characterization of the Cartilage DNA Methylome in Knee and Hip Osteoarthritis. Arthritis & Rheumatology. 66(9). 2450–2460. 135 indexed citations

13.

Xue, Yuan, Michael D. Rushton, & Laura Maringele. (2011). A Novel Checkpoint and RPA Inhibitory Pathway Regulated by Rif1. PLoS Genetics. 7(12). e1002417–e1002417. 41 indexed citations

14.

Allegrucci, Cinzia, Michael D. Rushton, James E. Dixon, et al.. (2011). Epigenetic reprogramming of breast cancer cells with oocyte extracts. Molecular Cancer. 10(1). 7–7. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact